Newsroom
All news stories Latest news
Featured
Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated
Press Release, Financial Results 25 April 2024
- Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting Press Release, Corporate 06 June 2024 Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House meeting
- Hikma opens new UK office to support NHS supply, strengthening European presence Press Release, Corporate 03 June 2024 Hikma opens new UK office to support NHS supply, strengthening European presence
- Hikma enters the Spanish generic injectables market, strengthening its European presence Press Release, Corporate 20 May 2024 Hikma enters the Spanish generic injectables market, strengthening its European presence
- Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US Press Release, Corporate 08 May 2024 Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US